Yourgene Health Share Discussion Threads

[swiftnick] 10/7/2019 09:39

So the combined business is still EBITDA negative.Yourgene -£3.1mElucigene + £1.0mSynergy cost savings from merger +£0.5mNet -£1.6mNot surprised to see the share price marked down. A lot of work still to do.

[twix386] 09/7/2019 13:25

That would be good Jonnycj.

Too many times (every time to date) we have expected the latest expectations/news will not disappoint in share price terms like the previous ones have.

Real quantifiable news. Material contracts with numbers.
Not attending conferences, dilution and no contract news for over a year!

Could this be the time? It would be about time!!!

We have made good progress under new ceo and tomorrow's rns should underpin our progress and prospects. The future looks the best it's ever been.

I hope we can deliver shareholder value (a re-rate) before the next funding!

[jonnycj] 09/7/2019 13:14

Comprehensive, fully informed broker note with sensible TP would be my guess and share price will trend towards it. Bear in mind it’s now a multi faceted business, so lots of revenue streams to forecast.

Exciting times ahead !

[twix386] 09/7/2019 12:53

Yup, I think likewise - No re-rate on the cards STILL for tomorrow's rns, but could see a spike or rise over a few days before falling back.

My hope would be that after results and broker note a material contract rns (with figures) will propel us into some sort of re-rate when all added together - well 15p+ anyway.

MUST be about time we secured a material contract or one deemed worthy of letting us know about!!

This share has been terminally disappointing in terms of share price.

[timojelly] 09/7/2019 12:25

Early spike then into negative /flat territory.

[spoll] 09/7/2019 12:02

Based on lack of buying this week I'd say the odds usual anti-climax.

Hopefully we will get some Q1 figures for the current year - optimistically maybe a figure of around 30,000 tests for this?

Personally not expecting any contract news.

When one lands then I would hope it to be of significance after all this time as per India last June (which I believe experienced delays but now up and running so it will be interesting to see whether the Q1 figures have jumped based on this).

Anyone following the Esperite woes won't be expecting much of an update on that as the recent announcements from them doesn't inspire confidence in them being able to pay us.

Evidence of cross-selling into the Elucigene clients would be welcome (and vice-versa).

Hopefully an update on our Illumina NIPT saying this is on track - meaning we will be able to compete in EU next year for some big contracts.

I don't want to read any reference to the handbrake being off unless accompanied by a big contract RNS! As always I hope this will be the start of the mystical re-rate.

[ikeadave] 09/7/2019 11:56

As long as the guidance is reasonable, I'm optimistic for 13 becoming support and building from there ...

[twix386] 09/7/2019 11:11

Straw poll....After tomorrow's rns do we think for the first time the share price is going to react by gradually and sustainably rising?It's not happened on prior hopes, but who knows we could even see the re-rate finally take hold. Usual anti-climax or long awaited re-rate?

[twix386] 07/7/2019 10:42

If we could manage to announce at least one material contract with figs, then the share price would react nicely! Let alone and on top of results and broker forecast.Please sir, can we sell our core nipt product or reduce our reporting barrier to levels where we can manage to put out at least one contract rns annually. For whatever reason we have not, It just seems poor, self inflicted and pathetic to witness this last 12+ months!Insufficient contract news cannot be ducked or excused much longer and I pray will be addressed in upcoming results. If the lack of news has been because individual contract wins have not been deemed material enough but have been evident, then even the simple fact therein that for over a year we have not had one sizeable contract win is damning enough. This is a REAL issue whatever the dynamics being applied to contract rns thresholds!

[jestercat2] 01/7/2019 19:44

My bad crow. Yep, that's exactly what I meant to say. Soz.

[jestercat2] 01/7/2019 14:12

The force is strong with this one today

[pyglet] 26/6/2019 15:37

Not sure why this is down today.

[scotty1] 25/6/2019 10:39

Obviously cannot be sure but looks to me like MMs want stock for a buyer dropping the share price 0.50p on very low volume sells,wouldn't be at all surprised to see a biggish buy later in the day,could also see the share price finish flat at end of play today,aimo of course.

[twix386] 25/6/2019 10:12

Give us some material contract news. It's been over a year since we had any reportable contract news, ffs!

[twix386] 25/6/2019 10:09

The usual share price move after news is conference attendance.

[twix386] 24/6/2019 12:41

Sorry Scotty,Most often its in reply to a comment as it was here and repetition isn't the same as wood for trees, if you can stay on theme please ;-)

[scotty1] 24/6/2019 12:14

The point is twix you continually post the same posts,whether you are right or wrong in your assumptions about TW.

[twix386] 24/6/2019 11:08

Anything I said that's incorrect Scotty?

[scotty1] 24/6/2019 10:59

Twix wood and trees comes to mind with your posts,as you say over the road Yawn 😊

[twix386] 24/6/2019 10:36

Yup, well over 2 years and counting! lolLike him or loath him, he's historically been atrocious with predictions and targets on Premaitha and so far on YourGene too. A stopped watch had a far better record.

[christopher logsdon] 24/6/2019 10:17

You know what guys I quite like TW spoken to him a few times, pinged him the odd email to but this so-called (material re-rate) is a long time coming!

[twix386] 24/6/2019 07:53

All to the good, but can't say I really care very much for this news when it could be long overdue material contract news etc.As news goes its more bread and butter.